Back
Cardiff Oncology Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
CRDF
Cardiff Oncology
Last Price:
$2.45
Seasonality Move:
11.94%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRDF is experiencing slight selling pressure.
Cardiff Oncology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.42 | Buy |
20-day SMA: | 2.95 | Sell |
50-day SMA: | 3.42 | Sell |
200-day SMA: | 3.42 | Sell |
8-day EMA: | 2.37 | Buy |
20-day EMA: | 1.86 | Buy |
50-day EMA: | 1.07 | Buy |
200-day EMA: | 0.33 | Buy |
Cardiff Oncology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.58 | Buy |
Relative Strength Index (14 RSI): | 34.95 | Sell |
Chaikin Money Flow: | -370309 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.39 - 4.05) | Sell |
Bollinger Bands (100): | (2.59 - 3.75) | Sell |
Cardiff Oncology Technical Analysis
Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cardiff Oncology Stock
Is Cardiff Oncology Stock a Buy?
-
Cardiff Oncology share price is 2.44 while CRDF 8-day simple moving average is 2.42, which is a Buy signal.
-
The stock price of CRDF is 2.44 while Cardiff Oncology 20-day SMA is 2.95, which makes it a Sell.
-
Cardiff Oncology 50-day simple moving average is 3.42 while CRDF share price is 2.44, making it a Sell technically.
-
CRDF stock price is 2.44 and Cardiff Oncology 200-day simple moving average is 3.42, creating a Sell signal.
CRDF Technical Analysis vs Fundamental Analysis
Sell
34
Cardiff Oncology (CRDF)
is a Sell
Is Cardiff Oncology a Buy or a Sell?
-
Cardiff Oncology stock is rated a SellThe current Cardiff Oncology [CRDF] share price is $2.44. The Score for CRDF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Cardiff Oncology Stock Info
Market Cap:
162.3M
Price in USD:
2.44
Share Volume:
1.4M
Cardiff Oncology 52-Week Range
52-Week High:
5.64
52-Week Low:
2.09
Sell
34
Cardiff Oncology (CRDF)
is a Sell
Cardiff Oncology Share Price Forecast
-
What is the Cardiff Oncology stock price today?The Cardiff Oncology stock price is 2.44 USD today.
-
Will CRDF stock go up or go down?Cardiff Oncology> share price is forecast to RISE/FALL based on technical indicators
-
Is Cardiff Oncology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cardiff Oncology is overvalued.
Is Cardiff Oncology Stock a Buy?
-
Cardiff Oncology share price is 2.44 while CRDF 8-day exponential moving average is 2.37, which is a Buy signal.
-
The stock price of CRDF is 2.44 while Cardiff Oncology 20-day EMA is 1.86, which makes it a Buy.
-
Cardiff Oncology 50-day exponential moving average is 1.07 while CRDF share price is 2.44, making it a Buy technically.
-
CRDF stock price is 2.44 and Cardiff Oncology 200-day simple moving average is 0.33, creating a Buy signal.
Fundamental Analysis of Cardiff Oncology
Is Cardiff Oncology a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.14 per share, and a decrease next year of $0.02 per share.
Technical Analysis of Cardiff Oncology
Should I short Cardiff Oncology stock?
-
CRDF Moving Average Covergence Divergence (MACD) indicator is 0.58, suggesting Cardiff Oncology is a Buy
-
Cardiff Oncology Relative Strength Index (RSI) is 34.95, which suggest Cardiff Oncology is oversold
-
The Bollinger Bands (25) for Cardiff Oncology is (2.39 - 4.05), which suggest Cardiff Oncology is a Sell
-
The Bollinger Bands (100) for Cardiff Oncology is (2.59 - 3.75), which suggest Cardiff Oncology is a Sell
* Cardiff Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.